ArticleCureus2026
Fiber Tractography-Guided MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pallidothalamic tractotomy (PTT) ablation using MR-guided focused ultrasound (MRgFUS) is a potential treatment option for medically refractory Parkinson's disease (PD). Because the PTT is surrounded by critical neural structures, precise stereotactic targeting is essential to minimize neurological adverse events. Diffusion tensor imaging (DTI) fiber tractography may improve targeting accuracy through direct visualization of the PTT. We report a single case of staged bilateral PTT ablation using MRgFUS in a 45-year-old woman with advanced PD. During the first procedure, DTI fiber tractography was used to visualize the PTT and determine the stereotactic target. During the second procedure, contralateral targeting was performed using mirrored anatomical coordinates derived from the initial tractography findings in order to maintain anatomical consistency. Motor symptoms improved substantially following both procedures. The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III score improved from 24 to 11 after the first procedure and from 52 to 11 after the second procedure. No neurological adverse events were observed throughout the follow-up period. Although limited by the single-case design, this report suggests that DTI fiber tractography-guided targeting may improve the visualization and identification of the PTT during MRgFUS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.